VAC2VAC
Owner/Developer: Innovative Medicines Initiative (IMI)
| Country: | Germany |
|---|---|
| Languages: | English |
| Url: | http://www.vac2vac.eu |
| Contact: | http://www.vac2vac.eu/contact-0 |
| Description: |
VAC2VAC is a wide-ranging collaborative research project funded by IMI2 which aims to develop and validate quality testing approaches for both human and veterinary vaccines using non-animal methods. The initiative that started on 1 March 2016 aims to provide the data to support the ‘Consistency Approach’ for quality control of established vaccines. The current quality control approach for final products relies on in vivo methods. |
| Category: | Research Program/Project/Grant |
| Channel: | Website |
| Audience: | Industry |
| User access: | Open access |
| Updating frequency: | 2016 |
| Relevance: | Replacement - Reduction |
| Purpose: | Validation - Method development |
| Legislative framework: | Medicines legislation |
Thanks for your feedback! Please note that we cannot reply to you unless you send us an email.
What are you looking for?
We value your feedback so we can improve the information on the page. Please add your email address if you would like a reply. Thank you in advance for your help.!
Please contact us by email if you have any questions.